PharmaRadar360
PharmaRadar360
Intelligence Layer
🇺🇸·1d agoIndustry

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

The actual press release articles

Publisher

U
United Therapeutics

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

The actual press release articles

Source route

Continue on ir.unither.com

Leave the platform to read the original full article on the publisher site.

Source: United Therapeutics

Scope: Industry

Open original article
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure | PharmaRadar360